{
  "ptid_time": "013_S_1120_2006-11-22",
  "img_path": "/data/qiuhui/data/adni/images/013_S_1120/2006-11-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 50,424 mm³, 79.7% above the reference mean. With a Z-score of 1.82 (96.6th percentile), this represents moderate enlargement; whole brain volume measures 801,449 mm³, 17.8% below the reference mean. With a Z-score of -2.24 (1.3th percentile), this represents significant atrophy. ",
  "text_data": "Age is 77.9 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Endocrine-Metabolic; Hematopoietic-Lymphatic; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 29.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 619.80 pg/mL (mild reduced); Total tau: 244.40 pg/mL (normal ); Phosphorylated tau: 23.71 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant whole brain atrophy (Z-score -2.24, 1.3th percentile) and moderate ventricular enlargement (Z-score 1.82, 96.6th percentile), which are structural changes often associated with neurodegeneration. However, the MMSE score of 29 is within the normal range, and CSF biomarkers (Aβ mildly reduced, normal T-tau and P-tau) do not strongly support Alzheimer’s pathology.  \n\n**Diagnosis:** **MCI** (given the structural changes despite normal cognition, possibly early neurodegenerative changes)  \n**Confidence:** **Medium** (discrepancy between imaging and cognitive/CSF findings warrants caution)",
  "timestamp": "2025-07-25T23:25:08.344988"
}